SRPX2 also exhibited excellent antifibrosis effect via TGFβR1/SMAD3/SRPX2/AP1/SMAD7-positive feedback loop, indicating that SRPX2 might be a therapeutic target for inflammation and cancer-related inflammation for future cancer therapeutics [11]. Here, TGFBR1 is linked to cancer.